These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7452826)

  • 61. Renal osteodystrophy in children: the effect of hemodialysis and renal homotransplantation.
    Fine RN; Isaacson AS; Payne V; Grushkin CM
    J Pediatr; 1972 Feb; 80(2):243-9. PubMed ID: 4550451
    [No Abstract]   [Full Text] [Related]  

  • 62. [Differential effects of 1,25-hydroxycholecalciferol in uremic osteodystrophy].
    Tarchini R; Pacchiarotti P; Figus S; Perilli A; Baldelli S; Mioli V
    Minerva Nefrol; 1981; 28(2):147-50. PubMed ID: 6895244
    [No Abstract]   [Full Text] [Related]  

  • 63. [Bone disease in patients with chronic renal failure and during long-term hemodialysis].
    Flury W
    Ther Umsch; 1972 Sep; 29(9):554-9. PubMed ID: 4628712
    [No Abstract]   [Full Text] [Related]  

  • 64. The pathophysiology and management of renal bone disease in dialysis patients.
    Meers C; Morton AR; Toffelmire EB
    CANNT J; 1999; 9(2):24-9, 32-8; quiz 30-1, 39-40. PubMed ID: 11778255
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phosphorus Regulation in Chronic Kidney Disease.
    Suki WN; Moore LW
    Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):6-9. PubMed ID: 28298956
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Renal osteodystrophy; observations in patients treated with chronic intermittent hemodialysis].
    Fieren M; Vermeulen A; Mulder AW
    Ned Tijdschr Geneeskd; 1979 Feb; 123(8):289-92. PubMed ID: 418927
    [No Abstract]   [Full Text] [Related]  

  • 67. [Renal osteodystrophy].
    Schober HC
    Z Urol Nephrol; 1986 Oct; 79(10):595-602. PubMed ID: 3811647
    [No Abstract]   [Full Text] [Related]  

  • 68. [Renal osteodystrophy and its possible correction in patients on chronic hemodialysis].
    Rozental' RL; Babarykin DA; Tikhomirova TE; Il'inskiĭ IM; Chernevskis KhK
    Ter Arkh; 1986; 58(1):105-8. PubMed ID: 3961679
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Symposium on Endocrine Functions of the Kidney. Foreword.
    Rubin AL; Cheigh JS; Stenzel KH
    Am J Med; 1975 Jan; 58(1):1-3. PubMed ID: 1115062
    [No Abstract]   [Full Text] [Related]  

  • 70. [The course of osteodystrophy in patients with chronic kidney failure on hemodialysis].
    Zemchenko AIu; Shostka GD
    Urol Nefrol (Mosk); 1993; (6):51-4. PubMed ID: 8160326
    [No Abstract]   [Full Text] [Related]  

  • 71. [Skeletal and soft part changes in patients on chronic dialysis].
    Herrmann K; Krohs G
    Z Gesamte Inn Med; 1974 Nov; 29(21):891-5. PubMed ID: 4462343
    [No Abstract]   [Full Text] [Related]  

  • 72. [Evolution of surgical methods in the treatment of renal osteodystrophy. Personal cases and remote results].
    Borrelli D; Cicchi P; Burci P; Perigli G; Bandini S; Solfanelli E
    Minerva Med; 1985 Mar; 76(9-10):429-39. PubMed ID: 3982701
    [No Abstract]   [Full Text] [Related]  

  • 73. [Adynamic bone disease and relative hypoparathyroidism in uremia].
    Mora C; Navarro JF
    Nefrologia; 2001; 21(1):26-40. PubMed ID: 11344959
    [No Abstract]   [Full Text] [Related]  

  • 74. Focus on vitamin D therapy in chronic kidney disease.
    Tentori F
    J Nephrol; 2007; 20(5):511-4. PubMed ID: 17918134
    [No Abstract]   [Full Text] [Related]  

  • 75. Osteodystrophy in patients with chronic renal failure.
    Fearing MO
    Nurs Clin North Am; 1975 Sep; 10(3):461-8. PubMed ID: 1041628
    [No Abstract]   [Full Text] [Related]  

  • 76. Management of bone disease in the dialysis patient.
    Crooks PW; Coburn JW
    Blood Purif; 1985; 3(1-3):27-41. PubMed ID: 3913448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Subtotal parathyroidectomy in the advanced stages of renal osteodystrophy].
    Giertler R; Pfann B; Scheler U; Schmidt U; Scheibner K
    Z Urol Nephrol; 1979 Jul; 72(12):523-30. PubMed ID: 525073
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
    Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
    Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preferential bone mineral loss in postmenopausal dialysed women?
    Kiss E; Rajtar M; Sonkodi S
    Nephrol Dial Transplant; 1996 Apr; 11(4):748-9. PubMed ID: 8671880
    [No Abstract]   [Full Text] [Related]  

  • 80. Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients.
    Paquot F; Delanaye P; Warling X; Moonen M; Smelten N; Jouret F; Krzesinski JM; Maillard N; Pottel H; Evenepoel P; Cavalier E
    Clin Chim Acta; 2018 Nov; 486():183-184. PubMed ID: 30086264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.